NovaBay Pharmaceuticals (NBY) Finished Goods (2016 - 2024)
Historic Finished Goods for NovaBay Pharmaceuticals (NBY) over the last 12 years, with Q4 2024 value amounting to $792000.0.
- NovaBay Pharmaceuticals' Finished Goods fell 6346.86% to $792000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $792000.0, marking a year-over-year decrease of 6346.86%. This contributed to the annual value of $792000.0 for FY2024, which is 6346.86% down from last year.
- NovaBay Pharmaceuticals' Finished Goods amounted to $792000.0 in Q4 2024, which was down 6346.86% from $732000.0 recorded in Q1 2024.
- In the past 5 years, NovaBay Pharmaceuticals' Finished Goods ranged from a high of $3.3 million in Q3 2022 and a low of $573000.0 during Q2 2021
- Moreover, its 5-year median value for Finished Goods was $1.5 million (2021), whereas its average is $1.8 million.
- In the last 5 years, NovaBay Pharmaceuticals' Finished Goods surged by 42076.79% in 2022 and then plummeted by 7716.07% in 2024.
- Over the past 5 years, NovaBay Pharmaceuticals' Finished Goods (Quarter) stood at $685000.0 in 2020, then soared by 291.53% to $2.7 million in 2021, then dropped by 0.71% to $2.7 million in 2022, then decreased by 18.59% to $2.2 million in 2023, then tumbled by 63.47% to $792000.0 in 2024.
- Its Finished Goods was $792000.0 in Q4 2024, compared to $732000.0 in Q1 2024 and $2.2 million in Q4 2023.